MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647125650 A) filed by Enveda Therapeutics, Inc. on October 21, 2026, for Multi-Omic Patient Stratification In Inflammatory Bowel Disease Treatment.
Inventors include Preto, Antnio, Jos; Chanana, Shaurya; Ence, Daniel; Domingo-Fernndez, Daniel; and Paul, Kiana.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The disclosed method and system pertain to stratifying a patient population for precision medicine in Inflammatory Bowel Disease (IBD) treatment. The method involves accessing a multi-omic dataset comprising genomic, transcriptomic, and proteomic profiles of patient data. Machine learning algorithms are employed to analyze the dataset and identify biomarkers associated with a response to a drug for treating IBD. The patient population is stratified into phenotypic groups based on the identified biomarkers using unsupervised clustering. A patient population predicted to respond to the drug is defined based on the stratification and further analysis of patient metadata. The system includes a data storage unit and a processor configured to perform the method. The method and system can be used to optimize therapeutic interventions in IBD management.
Disclaimer: Curated by HT Syndication.
